B-cell Chronic Lymphocytic Leukemia CLL Clinical Trial
Official title:
Phase II Multicentric, Randomized Trial, Exploring Intensified Rituximab Prephase Monotherapy Before Standard Fludarabine-Cyclophosphamide-Rituximab Regimen in Previously Untreated Symptomatic B-cell Chronic Lymphocytic Leukemia
Phase II, multicenter, randomized trial, exploring intensified Rituximab prephase
monotherapy before standard Fludarabine-Cyclophosphamide-Rituximab FC-R regimen in
previously untreated symptomatic B-cell chronic lymphocytic leukemia CLL.
A Study from the Goelams GCFLLCMW intergroup
Young fit medically B Cell untreated patients Comparison between FCR treatment = 6 FCR cycles and a the addition of a prephase with R Dense treatment before the 6 FCR cycles. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment